Showing results (31-40 of 247) with videos related to
Sort By:
Pageof 25
Cytokine & Growth Factor Reviews|August 28, 1998
FLT3: receptor and ligand. Biology and potential clinical applicationM R Shurin, C Esche, M T LotzeJournal of Molecular Medicine (Berlin, Germany)|July 1, 1997
Gene-based strategies for the immunotherapy of cancerT Tüting, W J Storkus, M T LotzeScandinavian Journal of Immunology|February 12, 2008
Coordinate NF-kappaB and STAT1 activation promotes development of myeloid type 1 dendritic cellsJ Vakkila, R A Demarco, M T LotzeCancer|December 1, 1988
Colonic perforation. An unusual complication of therapy with high-dose interleukin-2D Schwartzentruber, M T Lotze, S A RosenbergThe Journal of Experimental Medicine|December 1, 1988
Interleukin 4 promotes the growth of tumor-infiltrating lymphocytes cytotoxic for human autologous melanomaY Kawakami, S A Rosenberg, M T LotzeCurrent Opinion in Molecular Therapeutics|March 16, 2001
The use of dendritic cells for cancer vaccinationC Esche, M R Shurin, M T LotzeJournal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|November 1, 1993
Expansion of tumor-infiltrating lymphocytes from human tumors using the T-cell growth factors interleukin-2 and interleukin-4Y Kawakami, G P Haas, M T LotzeGene Therapy|January 19, 2000
Interferon-alpha gene therapy in combination with CD80 transduction reduces tumorigenicity and growth of established tumor in poorly immunogenic tumor modelsK Hiroishi, T Tüting, H Tahara, et al.Human Gene Therapy|March 1, 1996
Successful culture and selection of cytokine gene-modified human dermal fibroblasts for the biologic therapy of patients with cancerE M Elder, M T Lotze, T L WhitesideCurrent Opinion in Oncology|December 1, 1992
New biologic agents come to bat for cancer therapyM T Lotze, J T Rubin, H J ZehPageof 25